HRA Pharma Sees Good Prospects For Austria

HRA tells HBW Insight that it is seeing “a lot of growth opportunities” in the Austrian market as it takes back direct distribution of its leading consumer healthcare brands.

EUMap_Pills
• Source: Shutterstock

HRA Pharma SA has taken over distribution of its consumer healthcare brands in Austria after identifying good growth prospects in the market.

Having previously partnered with local player Sanova Pharma, HRA said it had transferred the distribution of its full portfolio in Austria to

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business